Coloplast reports growth
By HME News Staff
Updated 10:03 AM CST, Thu January 27, 2022
HUMLEBAEK, Denmark – Coloplast saw 6% organic growth in its first quarter ended Dec. 31. Reported revenue in DKK was up by 9% to DKK 5,169 million. Organic growth rates by business area were ostomy care 6%, continence care 5%, interventional urology 5% and wound & skin care 12%. EBIT before special items was DKK 1,649 million, a 7% increase from last year, corresponding to an EBIT margin before special items of 32% against 32% last year. EBIT after special items was DKK 1,615 million, a 5% increase from last year, corresponding to an EBIT margin after special items of 31% (special items were DKK 34 million related to Atos Medical, which Coloplast announced Nov. 8, 2021, it had acquired).
Comments